Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data FOXO TECHNOLOGIES INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0.12
0.51
0.15
4.05
16.4
Cost of revenue
0.12
0.34
0.13
Gross profit
0.12
0.17
0.01
Research and development
4.88
3.05
0.9
0.31
0.18
Selling, general and administrative
10.3
25.8
19.4
7.23
11.4
Operating expenses
15.2
40.3
22.3
11.8
26.7
Operating income
-15
-40.2
-22.2
-7.76
-10.3
Interest expense
1.12
1.44
1.06
3.91
3.43
Interest income
0.03
Other non-operating income
-0.24
-55.1
-4.26
-4.66
-2.3
Pre-tax income
-38.5
-95.3
-26.5
-12.4
-12.6
Income tax
-0.18
Net income to minority interests
-0.01
-0.02
Net income
-38.5
-95.3
-26.5
-12.4
-12.4
EBITDA
-14.9
-38.7
-20.9
-6.53
-9.73
Balance sheet
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
6.86
5.52
0.04
0.07
0.21
Receivables
2.27
2.47
Inventory
0.3
1.31
0.16
0.18
Other current assets
0.02
0.11
0.11
0.09
0.16
Total current assets
7.62
12.3
0.23
2.88
3.11
Property, plant and equipment
0.19
0.01
0.36
0.32
Lease right-of-use assets
3.98
3.55
Goodwill
25.5
27.8
Intangible assets
0.19
2.04
0.38
9.02
9.77
Other non-current assets
0.1
Total assets
30.3
35.4
0.73
41.7
44.6
Accounts payable
3.46
3.47
4.56
6.68
6.97
Accrued liabilities
1.05
3.98
12
11.9
Total current liabilities
36.1
6.91
14.3
31.2
28.7
Long-term debt
1.73
Lease liabilities
3.67
3.17
Other non-current liabilities
0.48
Total liabilities
55.5
28.7
14.8
36.4
33.5
Paid-in capital
4.9
154
163
196
236
Retained earnings
-52
-147
-177
-191
-225
Shareholders' equity
-25.2
6.71
-14.1
5.32
11.1
Minority interests
-0.05
-0.07
Total equity
-25.2
6.71
-14.1
5.27
11.1
Total liabilities and equity
30.3
35.4
0.73
41.7
44.6
Cash flow statement
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
4.65
-95.3
-26.5
-12.4
-12.4
Depreciation and amortization
0.1
1.49
1.28
1.24
0.6
Stock-based compensation
0.13
11
0.38
-0.1
-0.16
Deferred income tax
-0.18
Change in receivables
0.55
-0.12
Change in inventory
0.04
-0.01
Change in payables
3.09
0.13
0.5
1.16
0.19
Cash from operations
-15.1
-23.8
-6.65
-2.84
-3.87
Capital expenditures
-0.12
-0.11
-0.06
Acquisitions
-0.06
0.01
Purchases of investments
-0.05
Cash from investing
-0.36
-1.87
0.01
-0.66
Debt issued
7.25
28
Debt repaid
-0.6
-0.3
Stock issued
-30.6
Cash from financing
14.1
24.3
1.17
2.86
4.66
Net change in cash
-1.27
-1.34
-5.48
0.03
0.14
Free cash flow
-15.2
-23.9
-3.93
Interest paid
1.13
1.22
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.14 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-4.9%
Operating income / revenue.
EBITDA margin
-1.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-26.9%
Pre-tax income / revenue.
Net margin
-25.8%
Net income / revenue.
Operating cash flow margin
-2.4%
Cash from operations / revenue.
Return on equity (ROE)
-465.8%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-10.0%
Net income / average total assets.
Return on invested capital (ROIC)
-74.6%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
1.0%
Research and development expense / revenue.
SG&A / revenue
64.6%
Selling, general and administrative expense / revenue.
D&A / revenue
3.7%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
304.0%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
217.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
109.3%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
18.4%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
6.9%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
8.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.12x
Current assets / current liabilities.
Quick ratio
0.10x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.00x
(Cash + short-term investments) / current liabilities.
Market cap + total debt - cash - short-term investments.
P/S
0.01x
Market cap / revenue.
P/B
0.23x
Market cap / shareholders' equity. Only when equity is positive.
EV/Sales
0.01x
Enterprise value / revenue.
Earnings yield
-1,986.0%
Net income / market cap (the inverse of P/E).
What was FOXO TECHNOLOGIES INC.'s revenue in fiscal 2025?
FOXO TECHNOLOGIES INC. reported revenue of $16.4M for fiscal 2025, 304% higher than the year before.
Was FOXO TECHNOLOGIES INC. profitable in fiscal 2025?
No. It reported a net loss of $12.4M.
How much free cash flow did FOXO TECHNOLOGIES INC. generate in fiscal 2025?
Cash from operations of $3.9M minus capital expenditures of $62.0K left free cash flow of -$3.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.